Highlights HCW Biologics Inc.

Equities

HCWB

US40423R1059

Market Closed - Nasdaq Other stock markets 04:30:00 2024-07-16 pm EDT			5-day change	1st Jan Change
0.64 ^USD	-8.57%		+3.23%	-47.76%

May. 16	HCW Biologics Inc. announced that it expects to receive $10 million in funding	CI
May. 15	HCW Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HCW Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
HCW Biologics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Apr. 01	CI
HCW Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q3 Revenue $853,102	Nov. 14	MT
HCW Biologics Inc. Announces Results from Preliminary Human Data Readout from an Ongoing Phase 1 Clinical Trial Sponsored by the University of Minnesota	Nov. 08	CI
HCW Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q2 Revenue $622,807	23-08-11	MT
HCW Biologics Says It Received Patent for Methods to Treat Diseases Caused by Chronic Inflammation	23-06-14	MT
HCW Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
HCW Biologics Inc. Enters Cooperative Research and Development Agreement with National Cancer Institute	22-12-08	CI
HCW Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-07	CI
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q3 Revenue $361.8M	22-11-07	MT
HCW Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q2 Revenue $166,800	22-08-12	MT
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q1 Revenue $3.12M	22-05-13	MT
HCW Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-29	CI
HCW Biologics Shares Surge After FDA Approves Study of Pancreatic Cancer Treatment Candidate	21-10-28	MT
HCW Biologics Receives FDA Clearance to Proceed with Phase 1b Clinical Trial for Immunotherapeutic HCW9218 for Pancreatic Cancer	21-10-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights HCW Biologics Inc.

Equities

HCWB

US40423R1059

Highlights

Filters